Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / American Depositary Shares, or ADSs, each representing twenty-five common shares
-
Shares outstanding
-
1,728,859,840
-
Number of holders
-
32
-
Total 13F shares, excl. options
-
8,746,147
-
Shares change
-
+3,360,797
-
Total reported value, excl. options
-
$154,793,688
-
Value change
-
+$59,365,286
-
Number of buys
-
30
-
Price
-
$17.72
Institutional Holders of VEON Ltd. - American Depositary Shares, or ADSs, each representing twenty-five common shares (VEON) as of Q1 2023
As of 31 Mar 2023 VEON Ltd. - American Depositary Shares, or ADSs, each representing twenty-five common shares (VEON) had 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 8,746,147 shares of stock of the company.
Largest 10 holders included Exor Capital LLP, Helikon Investments Ltd, Solus Alternative Asset Management LP, BNP PARIBAS ASSET MANAGEMENT Holding S.A., WELLINGTON MANAGEMENT GROUP LLP, DG Capital Management, LLC, Kopernik Global Investors, LLC, GABELLI FUNDS LLC, Russell Investments Group, Ltd., and UBS ASSET MANAGEMENT AMERICAS INC.
This table shows 37 institutional shareholders of the security as of 31 Mar 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.